Trina Solar to Unveil New Utility-Scale Solar Module at Solarexpo 2010 in Italy

Trina Solar Limited (NYSE: TSL) ("Trina Solar" or the "Company"), a leading integrated manufacturer of solar photovoltaic (PV) products from the production of ingots, wafers and cells to the assembly of PV modules, today announced that its subsidiary, Changzhou Trina Solar Energy Co., Ltd., is launching its new utility-scale solar module ("TSM-PC14").

Trina Solar will unveil the new TSM-PC14 in May at Solarexpo 2010 in Verona, Italy. The utility-scale module is Trina Solar's most powerful module to date and is targeted to be available for sale in the European and North American markets in the fourth quarter of 2010.

With expected power output targets ranging from 265 to 290 watts, a positive power tolerance of 0/+3% and with a 72 cell arrangement, the large high-wattage modules are designed specifically for utility-scale installations and large scale, ground mounted systems. Equipped with high-efficiency multicrystalline cells, the TSM-PC14 is easy to handle and install and can be used in a wide variety of applications ranging from commercial and industrial installations to utility-scale facilities.

"Built to address increasing market demand for utility-scale solar installations around the world, this is our most powerful module and an excellent addition to our premium multicrystalline portfolio," said Mr. Jifan Gao, Chairman and CEO of Trina Solar. "Matching a competitive priced structure with proven high performance modules is the way the solar industry will achieve grid parity, and the introduction of the TSM-PC14 is a big step towards achieving this goal."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.